3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia
24
Leukemia, Myeloid, Acute
13
Lymphoma
12
Congenital Abnormalities
11
Lymphoma, Follicular
10
Head and Neck Neoplasms
10
Breast Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Mantle-Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Sarcoma
6
Precancerous Conditions
6
Neuroblastoma
6
Multiple Myeloma
6
Melanoma
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myeloid, Chronic-Phase
6
Kidney Neoplasms
6
Hodgkin Disease
6
Colonic Neoplasms
6
Burkitt Lymphoma
6
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Non-Hodgkin
5
Colorectal Neoplasms
5
Wilms Tumor
4
Interventions
Cisplatin
45
Radiotherapy
32
Fluorouracil
27
Paclitaxel
26
Irinotecan
17
Docetaxel
16
Oxaliplatin
11
Carboplatin
10
pembrolizumab
9
Cetuximab
8
tislelizumab
7
Surgical Procedures, Operative
7
Neoadjuvant Therapy
7
Drug Therapy
7
Radiation
6
Leucovorin
6
sintilimab
5
Nivolumab
5
Immunohistochemistry
5
Chemotherapy, Adjuvant
5
Capecitabine
5
nedaplatin
3
durvalumab
3
camrelizumab
3
S 1 (combination)
3
Magnetic Resonance Spectroscopy
3
Gene Expression Profiling
3
Gemcitabine
3
Fluorodeoxyglucose F18
3
Erlotinib Hydrochloride
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Esophageal Squamous Cell Carcinoma
×
Polymerase Chain Reaction
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled